Other — Revenue
Biogen Other — Revenue decreased by 15.7% to $55.40M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 88.4%, from $29.40M to $55.40M. Over 3 years (FY 2021 to FY 2025), Other — Revenue shows an upward trend with a 141.5% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
Growth in this metric indicates successful diversification or the scaling of minor business units, whereas a decline reflects the consolidation or divestiture of non-core operations.
Detailed definition
This metric tracks the specific revenue stream attributed to the 'Other' business category, encompassing miscellaneous p...
Peer comparison
Similar to 'Other' segment reporting in pharmaceutical and biotech firms, where it captures non-core royalties, service contracts, or minor product lines.
biib_segment_other_revenueHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $3.50M | $3.50M | $3.50M | $3.25M | $3.25M | $3.25M | $3.25M | $3.40M | $2.00M | $15.20M | $17.60M | $24.10M | $25.60M | $29.40M | $46.80M | $55.30M | $65.70M | $55.40M |
| QoQ Change | — | +0.0% | +0.0% | -7.1% | +0.0% | +0.0% | +0.0% | +4.6% | -41.2% | +660.0% | +15.8% | +36.9% | +6.2% | +14.8% | +59.2% | +18.2% | +18.8% | -15.7% |
| YoY Change | — | — | — | — | -7.1% | -7.1% | -7.1% | +4.6% | -38.5% | — | +417.6% | >999% | — | +93.4% | +165.9% | +129.5% | +156.6% | +88.4% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Biogen's other — revenue?
- Biogen (BIIB) reported other — revenue of $55.40M in Q1 2026.
- How has Biogen's other — revenue changed year-over-year?
- Biogen's other — revenue increased by 88.4% year-over-year, from $29.40M to $55.40M.
- What is the long-term trend for Biogen's other — revenue?
- Over 3 years (2021 to 2025), Biogen's other — revenue has grown at a 141.5% compound annual growth rate (CAGR), from $14.00M to $197.20M.
- What does other — revenue mean?
- Revenue attributed to miscellaneous business activities not classified within primary segments.